Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes
Purpose. - To evaluate the efficiency fo intravitreal ranibizumb for the treatment of neovascular age-related macular degeneration (nAMD) patients with a visual acuity (VA) of >= 20/40 and to investigate the predictive factors for visual outcomes
